The Specific Requirements of Neural Repair Trials for Stroke

Neurorehabilitation and Neural Repair

Volumn 30, Issue 5, 2016, Pages 470-478

  Dobkin, Bruce H ^a   Carmichael, S Thomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

axonal sprouting; clinical trials; mHealth; brain tissue regeneration; neuronal plasticity; physical therapy; stem cell; stroke rehabilitation

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; EXERCISE; HEMIPLEGIA; HOME MONITORING; HUMAN; LOWER LIMB; NEUROREHABILITATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; TIME; TISSUE REPAIR; UPPER LIMB; ANIMAL; BRAIN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STROKE REHABILITATION;

ANIMALS; BRAIN; HUMANS; RECOVERY OF FUNCTION; STROKE; STROKE REHABILITATION;

EID: 84965057087     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968315604400     Document Type: Article

References (54)

1. Mack G,. ReNeuron and stem cells get green light for neural stem cell trials. Nat Biotechnol. 2011; 29: 95-97.
2. SanBio announces the first public presentation of data from its on-going human clinical trial of cell therapy for chronic stroke disability. http://www.firstwordpharma.com/node/1188336#axzz3YWUZHFBZ. 2015. Accessed April 25, 2015.
3. Lima C, Escada P, Pratas-Vital J, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 2010; 24: 10-22.
4. Tabakow P, Jarmundowicz W, Czapiga B, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 2013; 22: 1591-1612.
5. Enserink M,. Selling the stem cell dream. Science. 2006; 313: 160-163.
6. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013; 1: e259-e281.
7. Jorgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Stoier M, Olsen TS,. Outcome and time course of recovery in stroke. Part I: outcome. The Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995; 76: 399-405.
8. Jorgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Stoier M, Olsen TS,. Outcome and time course of recovery in stroke. Part II: time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995; 76: 406-412.
9. de Port IG, Kwakkel G, van Wijk I, Lindeman E,. Susceptibility to deterioration of mobility long-term after stroke: a prospective cohort study. Stroke. 2006; 37: 167-171.
10. Prabhakaran S, Zarahn E, Riley C, et al. Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair. 2008; 22: 64-71.
11. Winters C, van Wegen EE, Daffertshofer A, Kwakkel G,. Generalizability of the proportional recovery model for the upper extremity after an ischemic stroke. Neurorehabil Neural Repair. 2015; 29: 614-622.
12. Byblow WD, Stinear CM, Barber PA, Petoe MA, Ackerley SJ,. Proportional recovery after stroke depends on corticomotor integrity [published online July 7, 2015]. Ann Neurol. doi: 10.1002/ana.24472.
13. Pollock A, Baer G, Campbell P, et al. Physical rehabilitation approaches for the recovery of function and mobility after stroke: major update. Cochrane Database Syst Rev. 2014; 4:CD001920.
14. Levin M, Kleim J, Wolf S,. What do motor
15. Alaverdashvili M, Whishaw I,. A behavioral method for identifying recovery and compensation: hand use in a preclinical stroke model using the single pellet reaching task. Neurosci Biobehav Rev. 2013; 37: 950-967.
16. Lo AC, Guarino PD, Richards LG, et al. Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med. 2010; 362: 1772-1783.
17. Wolf SL, Winstein CJ, Miller JP, et al.EXCITE Investigators. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA. 2006; 296: 2095-2104.
18. Duncan PW, Sullivan KJ, Behrman AL, et al.LEAPS Investigative Team. Body-weight-supported treadmill rehabilitation program after stroke. N Engl J Med. 2011; 364: 2026-2036.
19. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011; 10: 123-130.
20. Biernaskie J, Chernenko G, Corbett D,. Efficacy of rehabiliitative experience declines with time after focal ischemic brain injury. J Neurosci. 2004; 24: 1245-1254.
21. Clarkson A, Overman J, Zhong S, Mueller R, Lynch G, Carmichael S,. AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci. 2011; 31: 3766-3775.
22. Krakauer J, Carmichael S, Corbett D, Wittenberg G,. Getting neurorehabilitation right: what can be learned from animal models? Neurorehabil Neural Repair. 2012; 26: 923-931.
23. Hermann D, Chopp M,. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 2012; 11: 369-380.
24. Overman J, Carmichael S,. Plasticity in the injured brain: more than molecules matter. Neuroscientist. 2014; 20: 15-28.
25. Starkey M, Schwab M,. How plastic is the brain after a stroke? Neuroscientist. 2014; 20: 359-371.
26. Clarkson A, Huang B, Macisaac S, Mody I, Carmichael S,. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010; 468: 305-309.
27. Fang P, Barbay S, Plautz E, Hoover E, Strittmatter S, Nudo R,. Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke. 2010; 41: 544-549.
28. Wahl A-S, Schwab M,. Finding an optimal rehabilitation paradigm after stroke: enhancing fiber growth and training of the brain at the right moment. Front Hum Neurosci. 2014; 8: 381.
29. Overman J, Clarkson A, Wanner I, et al. A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proc Natl Acad Sci U S A. 2012; 109: E2230-E2239.
30. Lemmens R, Jaspers T, Robberecht W, Thijs V,. Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke. Hum Mol Genet. 2013; 22: 2214-2220.
31. Han J, Pollak J, Yang T, et al. Delayed administration of a small molecule tropomyosin-related kinase B ligand promotes recovery after hypoxic-ischemic stroke. Stroke. 2012; 43: 1918-1924.
32. Tornero D, Wattananit S, Madsen M, et al. Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain. 2013; 136 (pt 12): 3561-3577.
33. Kokaia Z, Lindvall O,. Stem cell repair of striatal ischemia. Prog Brain Res. 2012; 201: 35-53.
34. Horie N, Pereira M, Niizuma K, et al. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells. 2011; 29: 274-285.
35. Adkins DL, Boychuk J, Remple MS, Kleim JA,. Motor training induces experience-specific patterns of plasticity across motor cortex and spinal cord. J Appl Physiol. 2006; 101: 1776-1782.
36. Kleim J, Cooper N, VandenBerg P,. Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Res. 2002; 201: 1-6.
37. Fu M, Yu X, Lu J, Zuo Y,. Repetitive motor learning induces coordinated formation of clustered dendritic spines in vivo. Nature. 2012; 483: 92-95.
38. Zemmar A, Weinmann O, Kellner Y, et al. Neutralization of Nogo-A enhances synaptic plasticity in the rodent motor cortex and improves motor learning in vivo. J Neurosci. 2014; 26: 8685-8698.
39. Dunnett S,. Neural tissue transplantation, repair, and rehabilitation. Handb Clin Neurol. 2013; 110: 43-59.
40. Hicks AU, Hewlett K, Windle V, et al. Enriched environment enhances transplanted SVZ stem cell survival, migration and functional recovery after stroke. Neuroscience. 2007; 136: 31-40.
41. Gherardini L, Gennaro M, Pizzorusso T,. Perilesional treatment with chondroitinase ABC and motor training promote functional recovery after stroke in rats. Cereb Cortex. 2015; 25: 202-212.
42. Meyer S, Verheyden G, Brinkmann N, et al. Functional and motor outcome 5 years after stroke is equivalent to outcome at 2 months: follow-up of the collaborative evaluation of rehabilitation in stroke across Europe. Stroke. 2015; 46: 1613-1619.
43. Dong Y, Winstein CJ, Dobkin B, Singh M,. Changes in cortical motor activity with rehabilitative therapy in stroke: a longitudinal fMRI study. Poster presented at: 34th Annual Meeting of the Society for Neuroscience; October 23-27, 2004; San Diego, CA.
44. Ietswaart M, Johnston M, Dijkerman HC, et al. Mental practice with motor imagery in stroke recovery. Brain. 2011; 134 (pt 5): 1373-1386.
45. Dobkin B,. Wearable motion sensors to continuously measure real-world activities. Curr Opin Neurol. 2013; 26: 602-608.
46. Dorsch AK, Thomas S, Xu X, Kaiser W, Dobkin BH, SIRRACT Investigators. SIRRACT: an international randomized clinical trial of activity feedback during inpatient stroke rehabilitation enabled by wireless sensing. Neurorehabil Neural Repair. 2015; 29: 407-415.
47. Dobkin BH, Nadeau SC, Behrman AL, et al. Prediction of responders for outcome measures of locomotor Experience Applied Post Stroke trial. J Rehabil Res Dev. 2014; 51: 39-50.
48. Dobkin B, Dorsch A,. The promise of mHealth: daily activity monitoring and outcome assessments by wearable sensors. Neurorehabil Neural Repair. 2011; 25: 788-798.
49. Benvenuti F, Stuart M, Cappena V, et al. Community-based exercise for upper limb paresis: a controlled trial with telerehabilitation. Neurorehabil Neural Repair. 2014; 28: 611-620.
50. Dobkin B, Dorsch A,. New evidence for therapies in stroke rehabilitation. Curr Atheroscler Rep. 2013; 15: 331-340.
51. Carmel J, Kimura H, Martin J,. Electrical stimulation of motor cortex in the uninjured hemisphere after chronic unilateral injury promotes recovery of skilled locomotion through ipsilateral control. J Neurosci. 2014; 34: 462-466.
52. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke: bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009; 40: 510-515.
53. Cramer S, Koroshetz W, Finklestein S,. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke. 2007; 38: 1393-1395.
54. Velstra IM, Curt A, Frotzler A, et al. Changes in strength, sensation, and prehension in acute cervical spinal cord injury: European Multicenter Responsiveness Study of the GRASSP. Neurorehabil Neural Repair. 2015; 29: 755-766.